bpc-157 and tb & TB-500 Blend 10mg BPC-157 TB-500 5mg Research Blend

: NAD NMN/NR NNMT- (: NNMT NMN/ NNMT)

Mechanism of Action (Research Context) Pre-clinical research in lab models shows that BPC-157 modulates angiogenic growth factors and nitric oxide pathways, whereas TB-500 has an effect on the regulation of actin binding protein and cellular migration

TB-500's 7-day half-life means plasma levels remain therapeutic for 34 days post-injection

How much this role vs non-transmission-related functions of Agm mediate protection in age-related dementias is less clear, but a supporting role for Agm/Glu co-transmission is consistent with Agm protection against excitotoxicity in AD models (Zhu et al., 2003)